The American Journal of Cardiology®
Advanced SearchSave search
Roundtable discussion| Volume 102, ISSUE 5, P559-567, September 01, 2008

The Editor's Roundtable: Lipid Management Beyond Statins—Reducing Residual Cardiovascular Risk

  • Vincent E. Friedewald Jr.
    Correspondence
    Corresponding author: Tel: 512-264-1611; fax 512-264-7034
    Affiliations
    Assistant Editor, The American Journal of Cardiology, Clinical Professor, Department of Internal Medicine, The University of Texas Medical School at Houston, Houston, Texas, and Adjunct Research Professor, College of Science, University of Notre Dame, Notre Dame, Indiana
    Search for articles by this author
  • Christie M. Ballantyne
    Affiliations
    Director, Center for Cardiovascular Prevention, The Methodist DeBakey Heart Center and Baylor College of Medicine, and Professor, Section of Atherosclerosis, Department of Medicine, Baylor College of Medicine, Houston, Texas
    Search for articles by this author
  • Michael H. Davidson
    Affiliations
    Clinical Professor, Director of Preventive Cardiology, The University of Chicago, Pritzker School of Medicine, and Executive Medical Director, Radiant Research, Chicago, Illinois
    Search for articles by this author
  • John R. Guyton
    Affiliations
    Associate Professor of Medicine, Division of Endocrinology, Metabolism, and Nutrition, and Assistant Professor of Pathology, Duke University Medical Center, Durham, North Carolina
    Search for articles by this author
  • William C. Roberts
    Affiliations
    Editor-in-Chief, The American Journal of Cardiology and Baylor University Medical Center Proceedings, Executive Director, Baylor Heart and Vascular Institute, Baylor University Medical Center, and Dean, A. Webb Roberts Center for Continuing Medical Education of Baylor Health Care System, Dallas, Texas
    Search for articles by this author
DOI:https://doi.org/10.1016/j.amjcard.2008.06.028
The Editor's Roundtable: Lipid Management Beyond Statins—Reducing Residual Cardiovascular Risk
Previous ArticleOutcomes of Patients With Acute Coronary Syndrome and Previous Coronary Artery Bypass Grafting (from the Pravastatin or Atorvastatin Evaluation and Infection Therapy [PROVE IT-TIMI 22] and the Aggrastat to Zocor [A to Z] Trials)
Next ArticleChanging Trends of Hospital Utilization in Patients After Their First Episode of Atrial Fibrillation
      This CME activity is supported by an educational grant from Abbott Laboratories, Abbott Park, Illinois.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Register: Create an account
      Institutional Access: Sign in to ScienceDirect

      References

      1. Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults.
        JAMA. 2001; 285: 2486-2497
        View in Article
        • Smith S.C.
        • Allen J.
        • Blair S.N.
        • Bonow R.O.
        • Brass L.M.
        • Fonarow G.C.
        • Grundy S.M.
        • Hiratzka L.
        • Jones D.
        • Krumholz H.M.
        • et al.
        AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute.
        J Am Coll Cardiol. 2006; 47: 2130-2139
        View in Article
        • Davidson M.H.
        • Robinson J.G.
        Safety of aggressive lipid management.
        J Am Coll Cardiol. 2007; 49: 1753-1762
        View in Article
        • Kastelein J.J.
        • Sager P.T.
        • de Groot E.
        • Veltri E.
        Comparison of ezetimibe plus simvastatin versus simvastatin monotherapy on atherosclerosis progression in familial hypercholesterolemia.
        Am Heart J. 2005; 149: 234-239
        View in Article
        • Canner P.L.
        • Berge K.G.
        • Wenger N.K.
        • Stamler J.
        • Friedman L.
        • Prineas R.J.
        • Friedewald W.
        Fifteen year mortality in Coronary Drug Project patients: long-term benefit with niacin.
        J Am Coll Cardiol. 1986; 8: 1245-1255
        View in Article

      Article Info

      Footnotes

      This discussion took place on February 14, 2008, at Baylor University Medical Center, Dallas, Texas.

      Identification

      DOI: https://doi.org/10.1016/j.amjcard.2008.06.028

      Copyright

      © 2008 Elsevier Inc. Published by Elsevier Inc. All rights reserved.

      ScienceDirect

      Access this article on ScienceDirect
      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the for this site.
      Copyright © 2022 Elsevier Inc. except certain content provided by third parties. The content on this site is intended for healthcare professionals.


      RELX